Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192501 | SCV000246762 | likely benign | not specified | 2015-09-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001701554 | SCV000565769 | likely benign | not provided | 2020-09-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000535904 | SCV000639898 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354540 | SCV002652155 | benign | Inborn genetic diseases | 2023-03-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001701554 | SCV001932218 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701554 | SCV001974130 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000535904 | SCV002087264 | likely benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2019-10-24 | no assertion criteria provided | clinical testing |